http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 07 Jan 2025 06:23:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/Press+Releases/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/au..perth" idsrc="xmltag.org" >PERTH, Australia</location></span>, <span class="legendSpanClass"><chron>Jan. 7, 2025</chron></span> /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through neuro-immune modulation and advanced nano-medicine technology.</p> <p>The company announces the successful completion of a <money>US$4,500,000</money> (before costs) capital raise (<b>Placement</b>) through the subscription of 5,625,000 Units, each priced at <money>US$0.80</money> (<money>~A$1.28</money>). Each Unit comprises two (2) fully paid ordinary shares (<b>Placement Shares</b>) and one (1) free-attaching warrant, exercisable at <money>US$0.55</money> (<money>~A$0.88</money>) with an expiry date of three years from issuance (<b>Warrants</b>).</p> <p>The Placement will be conducted http://www.streetinsider.com/PRNewswire/Argent+BioPharma+Ltd.+Raised+US%244%2C500%2C000/24177132.html Tue, 07 Jan 2025 06:23:00 -0500 MXC O.03969348 RGT RGTLF RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html <p align="justify">HAMILTON, Ontario, March 25, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it is adding the first five hundred patients to their expanded mental health services portfolio and expects to add an additional 10,000 patients by the end of 2024.</p> <p align="justify">“We are very pleased to be adding the first five hundred patients in the US Virgin Islands, Florida and Nevada to our new http://www.streetinsider.com/Globe+Newswire/Reliq+Health+Technologies%2C+Inc.+Announces+Onboarding+of+New+Mental+Health+Patients+and+Management+Changes/22975748.html Mon, 25 Mar 2024 19:43:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Expansion+of+Mental+Health+Services/22845263.html <p align="justify">HAMILTON, Ontario, Feb. 27, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded its mental health services portfolio and expects to add 10,000 new mental health patients to its platform in 2024.</p> <p align="justify">“We are very pleased to be adding cognitive assessments to our portfolio of mental health services,” said Chris Shields, CEO at Reliq Health Technologies, Inc. “Many of our existing http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Expansion+of+Mental+Health+Services/22845263.html Tue, 27 Feb 2024 17:58:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Expansion+of+Mental+Health+Services/22845263.html <p align="justify">HAMILTON, Ontario, Feb. 27, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded its mental health services portfolio and expects to add 10,000 new mental health patients to its platform in 2024.</p> <p align="justify">“We are very pleased to be adding cognitive assessments to our portfolio of mental health services,” said Chris Shields, CEO at Reliq Health Technologies, Inc. “Many of our existing http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Expansion+of+Mental+Health+Services/22845263.html Tue, 27 Feb 2024 17:58:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Expansion+of+Mental+Health+Services/22845263.html <p align="justify">HAMILTON, Ontario, Feb. 27, 2024 (GLOBE NEWSWIRE) -- <strong>Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) </strong>(“<strong>Reliq</strong>” or the “<strong>Company</strong>”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded its mental health services portfolio and expects to add 10,000 new mental health patients to its platform in 2024.</p> <p align="justify">“We are very pleased to be adding cognitive assessments to our portfolio of mental health services,” said Chris Shields, CEO at Reliq Health Technologies, Inc. “Many of our existing http://www.streetinsider.com/Press+Releases/Reliq+Health+Technologies%2C+Inc.+Announces+Expansion+of+Mental+Health+Services/22845263.html Tue, 27 Feb 2024 17:58:00 -0500 A.36078215 MHN2 O.00783833 O.02596704 RHT RQHTF